Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AQXP

Aquinox Pharmaceuticals (AQXP) Stock Price, News & Analysis

Aquinox Pharmaceuticals logo

About Aquinox Pharmaceuticals Stock (NASDAQ:AQXP)

Advanced Chart

Key Stats

Today's Range
$19.37
$20.55
50-Day Range
$3.68
$4.03
52-Week Range
$2.00
$3.84
Volume
221,816 shs
Average Volume
239,362 shs
Market Capitalization
$459.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AQXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aquinox Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AQXP Stock News Headlines

Mirum Pharmaceuticals, Inc. (MIRM)
Why Aquinox Pharma (AQXP) Stock Might be a Great Pick
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
See More Headlines

AQXP Stock Analysis - Frequently Asked Questions

Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) issued its earnings results on Thursday, November, 8th. The company reported ($0.64) EPS for the quarter, missing the consensus estimate of ($0.21) by $0.43.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aquinox Pharmaceuticals investors own include Novavax (NVAX), Bausch Health Cos (BHC), Sarepta Therapeutics (SRPT), ACADIA Pharmaceuticals (ACAD), XOMA Royalty (XOMA), Alnylam Pharmaceuticals (ALNY) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/08/2018
Today
7/08/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:AQXP
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$31.58 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$25 million
Price / Cash Flow
N/A
Book Value
$3.09 per share
Price / Book
6.31

Miscellaneous

Free Float
N/A
Market Cap
$459.03 million
Optionable
Not Optionable
Beta
-7.37
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:AQXP) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners